Continuous Abstinence Rates from Smoking Over 12 Months according to the Frequency of Participation in a Hospital-based Smoking Cessation Program among Patients Discharged after Acute Myocardial Infarction

2016 ◽  
Vol 16 (1) ◽  
pp. 48
Author(s):  
Young-Hoon Lee ◽  
Mi-Hee Han ◽  
Mi Rim Lee ◽  
Jin-Won Jeong ◽  
Nam-Ho Kim ◽  
...  
2011 ◽  
Vol 162 (1) ◽  
pp. 74-80 ◽  
Author(s):  
David A. Katz ◽  
Fengming Tang ◽  
Babalola Faseru ◽  
Phillip A. Horwitz ◽  
Philip Jones ◽  
...  

2019 ◽  
pp. 089719001988974
Author(s):  
Mitsuko Onda ◽  
Takashi Kuwanoe ◽  
Atsunori Hashimoto ◽  
Michiko Horiguchi ◽  
Masayuki Domichi ◽  
...  

Aim: Although smoking cessation support has been recommended as a routine component of pharmacists’duties, there is limited evidence of smoking cessation being achieved successfully in community pharmacy. The aim of this study was to develop a new smoking cessation program for use in the community pharmacy setting and investigate its feasibility. Methods: A feasibility study (the Family pharmacist’s Intervention for Nicotine Elimination [FINE] program) was conducted using 8 pharmacists at 2 community pharmacies in Japan. The pharmacists recruited as subjects smokers 20 or more years of age who were taking medications such as antidiabetes drugs. The patients completed questionnaires assessing their smoking status, and the pharmacists provided them with smoking cessation support services. Participating patients met with the pharmacists or talked to them on the phone 5 times at 2- to 4-week intervals and received personalized and structured brief smoking cessation advice. The primary outcome was continuous abstinence determined by Micro Smokerlyzer carbon monoxide monitor at 3 months. Results: Of 5306 patients, 2296 patients were screened and the rate of smoking was found to be 12.7%. Five smoking patients received the FINE program from pharmacists who had received training. One of the 5 succeeded in quitting smoking after 3 months. Conclusions: This is the first study to target Japanese smoking patients in community pharmacies with a brief structured intervention. The results tentatively support the feasibility of the FINE program. Further research including a randomized controlled trial is required to confirm the effectiveness of the FINE program.


2014 ◽  
Vol 16 (9) ◽  
pp. 1224-1231 ◽  
Author(s):  
Li-Shiun Chen ◽  
Richard G. Bach ◽  
Petra A. Lenzini ◽  
John A. Spertus ◽  
Laura Jean Bierut ◽  
...  

1988 ◽  
Vol 13 (4) ◽  
pp. 331-335 ◽  
Author(s):  
C.B. Taylor ◽  
Nancy Houston-Miller ◽  
William L. Haskell ◽  
Robert F. Debusk

2018 ◽  
Vol 4 (Supplement) ◽  
Author(s):  
Regina Dalmau ◽  
Andrea Velez ◽  
Adrián Rivas ◽  
Javier Irazusta ◽  
Andrea Araujo ◽  
...  

2021 ◽  
Vol 15 (11) ◽  
pp. 3257-3260
Author(s):  
Ahsan Lakho ◽  
Muhammad Hassan Butt ◽  
Javed Khurshed Shaikh ◽  
Muhammad Hashim Kalwar ◽  
Gulzar Ali ◽  
...  

Objective: To determine the frequency of smokers and to compare the frequency of smokers among patients with inferior and anterior acute myocardial infarction amongst patients presenting with acute myocardial infarction at a Tertiary Care Hospital. Subjects And Methods: This cross-sectional study was conducted on 226 at the Adult Cardiology Department of the National Institute of Cardiovascular Disease (NICVD), Karachi for six months from 20-07-2019 till 20-01-2020. After obtaining verbal consent, researchers prospectively collected data from the participants. The study included 226 patients who were diagnosed with the appropriate conditions. Frequency and percentages were used to present qualitative data, while mean and standard deviation were used to present quantitative data. To see how to effect modifiers affected the outcome, researchers used stratification to keep track of them. For statistical significance, the post-stratification chi-square test was used. Results: A total of 226 presenting with acute myocardial infarction were included in this study. The mean age in our study was 55.92±10.49 years. Out of 226 patients with acute myocardial infarction, 130 (57.5%) and 96 (42.5) smoked and did not smoke respectively. Comparison of smoking status in patients who had anterior and inferior myocardial infarction showed that 39 (53.4%) and 51 (51%) smoked respectively. Conclusion: Smoking is a well-recognized strong modifiable risk factor and predictor of multivessel disease. Smoking cessation has been consistently associated with a mortality benefit in both stable coronary artery disease and post-acute coronary syndromes. Consequently, smoking cessation is one of the cornerstones of secondary prevention despite the improvement in the management of ACS with PCI and pharmacotherapy Keywords: Smoking, coronary vessels, territory and ST elevated myocardial infarction.


2013 ◽  
Vol 61 (5) ◽  
pp. 524-532 ◽  
Author(s):  
Mark J. Eisenberg ◽  
Sonia M. Grandi ◽  
André Gervais ◽  
Jennifer O'Loughlin ◽  
Gilles Paradis ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document